OncoMark Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.25M
Latest Deal Amount
  • Investors
  • 6

OncoMark General Information

Description

Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The company's device detects early stage breast cancer by measuring the expression of 3 prognostic genes (+ 3 reference genes) and estimates the probability of distant recurrence for breast cancer patients, enabling clinicians to determine treatment options for their patients and ultimately improving the patent's quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • NovaUCD, Belfield Innovation Park
  • Belfield
  • Dublin 4
  • Ireland
+353 (01) 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoMark Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 15-Feb-2017 $2.25M 00.000 Completed Generating Revenue
2. Grant 09-Sep-2015 00.000 Completed Startup
1. Grant $3.89M Completed Startup
To view OncoMark’s complete valuation and funding history, request access »

OncoMark Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The compan
Diagnostic Equipment
Dublin, Ireland
11 As of 2018
00.000
0000000000 0 00.000

0000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000000000000 00000000
Boston, MA
00 As of 0000
000.00
00000000000 000.00

00000000

mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
0000000000000
Gaithersburg, MD
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoMark Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Farcast Biosciences Venture Capital-Backed Boston, MA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000 00000
To view OncoMark’s complete competitors history, request access »

OncoMark Executive Team (6)

Name Title Board Seat Contact Info
Desmond O'Leary Chief Executive Officer & Board Member
William M. Gallagher Co-Founder, Chairman & Chief Scientific Officer
Stephen Penney Co-Founder, Board Member & Company Secretary
John Crown Chief Medical Officer
You’re viewing 4 of 6 executive team members. Get the full list »

OncoMark Board Members (5)

Name Representing Role Since
Cormac Kilty Ph.D Self Board Member 000 0000
Desmond O'Leary OncoMark Chief Executive Officer & Board Member 000 0000
Donal O'Shea Ph.D Self Board Member 000 0000
Stephen Penney OncoMark Co-Founder, Board Member & Company Secretary 000 0000
William M. Gallagher OncoMark Co-Founder, Chairman & Chief Scientific Officer 000 0000
To view OncoMark’s complete board members history, request access »

OncoMark Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoMark Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Enterprise Ireland Venture Capital Minority 000 0000 000000 0
Halo Business Angel Network Angel Group Minority 000 0000 000000 0
Irrus Investments Angel Group Minority 000 0000 000000 0
Kernel Capital (Ireland) Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »